Ipsen, GENFIT Enter Long-term Collaboration; Ipsen Becomes Shareholder Of GENFIT
17/12 07:23
(RTTNews) - Ipsen (IPSEY) and GENFIT (GNFT) said, under a long-term strategic partnership, Ipsen will gain exclusive worldwide license to develop, manufacture and commercialize GENFIT's investigational treatment elafibranor, for people living with Primary Biliary Cholangitis. The...